Findings

What do systematic reviews say?

7 questions · 7 findings · 1 reviews · Metabolic and Endocrine Disorders

No studies found 3 · 42.9%GRADE not reported 0 · 0%Very low 3 · 42.9%Low 1 · 14.3%Moderate 0 · 0%High 0 · 0%

Weight loss (change in kg weight) · overweight or obese adults

1 finding from 1 review

Fluoxetine for adults who are overweight or obese 2019 · Cochrane Headline outcomes only
no estimate extracted
10 studies · 956 participants
Very low

Health‐related quality of life · overweight or obese adults

The review found no eligible studies for this question.

1 finding from 1 review

Fluoxetine for adults who are overweight or obese 2019 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Any adverse event (N) · overweight or obese adults

Summary of findings: fluoxetine showed no clear difference in any adverse event (N) compared with placebo (low certainty).

1 finding from 1 review

Fluoxetine for adults who are overweight or obese 2019 · Cochrane Headline outcomes only
RR 1.18 [0.99, 1.42]
9 studies · 1253 participants
Low

Anthropometric measurements other than weight loss in kg (BMI reduction measured inkg/m²) · overweight or obese adults

1 finding from 1 review

Fluoxetine for adults who are overweight or obese 2019 · Cochrane Headline outcomes only
no estimate extracted
3 studies · 97 participants
Very low

Morbidity: depression (N) · overweight or obese adults

It is very uncertain whether summary of findings: fluoxetine changes morbidity: depression (N) compared with placebo (very low certainty).

1 finding from 1 review

Fluoxetine for adults who are overweight or obese 2019 · Cochrane Headline outcomes only
RR 1.2 [0.57, 2.52]
3 studies · 393 participants
Very low

All‐cause mortality · overweight or obese adults

The review found no eligible studies for this question.

1 finding from 1 review

Fluoxetine for adults who are overweight or obese 2019 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Socioeconomic effects · overweight or obese adults

The review found no eligible studies for this question.

1 finding from 1 review

Fluoxetine for adults who are overweight or obese 2019 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found